445 related articles for article (PubMed ID: 9236486)
21. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
Livermore DM; Wood MJ
Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
[TBL] [Abstract][Full Text] [Related]
22. Problems with detection of beta-lactam resistance among nonfastidious gram-negative bacilli.
Sanders CC; Thomson KS; Bradford PA
Infect Dis Clin North Am; 1993 Jun; 7(2):411-24. PubMed ID: 8345176
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactam antibiotics and beta-lactamases: two sides of a continuing story.
Richmond MH
Rev Infect Dis; 1979; 1(1):30-8. PubMed ID: 400938
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of resistance to beta-lactam antibiotics.
Livermore DM
Scand J Infect Dis Suppl; 1991; 78():7-16. PubMed ID: 1947825
[TBL] [Abstract][Full Text] [Related]
25. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
Sanders CC; Sanders WE
J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
[TBL] [Abstract][Full Text] [Related]
26. Clinical importance of inducible beta-lactamases in gram-negative bacteria.
Sanders CC; Sanders WE
Eur J Clin Microbiol; 1987 Aug; 6(4):435-8. PubMed ID: 3311737
[TBL] [Abstract][Full Text] [Related]
27. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
Neu HC
Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
Semenitz E
Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
[TBL] [Abstract][Full Text] [Related]
29. Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia.
Vargas-Alzate CA; Higuita-Gutiérrez LF; Jiménez-Quiceno JN
Biomedica; 2019 May; 39(s1):35-49. PubMed ID: 31529847
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance with focus on oral beta-lactamases.
Handal T; Olsen I
Eur J Oral Sci; 2000 Jun; 108(3):163-74. PubMed ID: 10872985
[TBL] [Abstract][Full Text] [Related]
31. Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium.
Thomson KS; Smith Moland E
Microbes Infect; 2000 Aug; 2(10):1225-35. PubMed ID: 11008112
[TBL] [Abstract][Full Text] [Related]
32. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.
Sanders CC; Sanders WE
J Infect Dis; 1985 Mar; 151(3):399-406. PubMed ID: 2982957
[TBL] [Abstract][Full Text] [Related]
33. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
34. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
[TBL] [Abstract][Full Text] [Related]
35. Problems and changing patterns of resistance with gram-negative bacteria.
Acar JF
Rev Infect Dis; 1985; 7 Suppl 4():S545-51. PubMed ID: 3909311
[TBL] [Abstract][Full Text] [Related]
36. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
37. [The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: current situation].
Martínez-Martínez L; Calvo J
Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():25-31. PubMed ID: 21130927
[TBL] [Abstract][Full Text] [Related]
38. [Bacterial resistance against beta-lactam antibiotics].
Andersen BM
Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
[TBL] [Abstract][Full Text] [Related]
39. β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
Gutkind GO; Di Conza J; Power P; Radice M
Curr Pharm Des; 2013; 19(2):164-208. PubMed ID: 22894615
[TBL] [Abstract][Full Text] [Related]
40. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
Bradford PA
Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
